Support The Moscow Times!

Russia Virus Cases Approach May High in 'Serious' Upturn

Moskva News Agency

Russia on Monday recorded a rise in coronavirus cases close to the maximum level in May but it has stopped short of reimposing strict lockdown measures.

With the fourth-highest number of cases in the global pandemic, Russia introduced harsh measures during the first outbreak of the virus including the closure of borders from March while Muscovites had to apply for electronic passes to travel round the city. 

On Monday, the government confirmed 10,888 new cases, approaching the May 11 highest recorded level of 11,656. 

Of these, 3,537 were in the capital, the worst-hit city by far, where Mayor Sergei Sobyanin said Sunday there are "many seriously ill."

Deputy Prime Minister Tatiana Golikova said Friday that a sharp upturn in cases since late September was "serious" but added that "we expected this," the TASS state news agency reported.

She cited people returning to workplaces and the rise in flu and pneumonia cases generally expected in autumn and winter.

In Moscow, the mayor has introduced some measures to slow the infection rate, telling those over 65 to stay at home and requiring companies to have at least 30 percent of staff working from home from Monday.

These measures fall far short of the tight lockdown that reached its height in Moscow in March. The capital saw its highest daily level of new cases in May, at 6,703, much higher than the current figure.

"I imagine a full self-isolation regime won't be reintroduced in Russia," Senator Valery Ryazansky told the RIA Novosti state news agency on Monday.

However he warned that a full border closure was possible.

"Of course we can close the Russia border. We are coming to this," he said.

Fears over the impact of the virus, among other factors, have hit the ruble, which last month slumped to its lowest level against the euro since 2016.

Russia has recorded 21,475 virus deaths.

It approved a vaccine called Sputnik V in August, claiming a world first, although large-scale clinical trials are continuing. Another Russian vaccine is also undergoing trials.

Sign up for our free weekly newsletter

Our weekly newsletter contains a hand-picked selection of news, features, analysis and more from The Moscow Times. You will receive it in your mailbox every Friday. Never miss the latest news from Russia. Preview
Subscribers agree to the Privacy Policy

A Message from The Moscow Times:

Dear readers,

We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."

These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.

We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.

By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.

Once
Monthly
Annual
Continue
paiment methods
Not ready to support today?
Remind me later.

Read more